Home/ Stocks/ BGMS

Bio Green Med Solution, Inc. Common Stock

BGMS XNAS

$1.01 -0.08 (-7.72%) ▼ 15-min delayed

Open

$1.08

High

$1.15

Low

$0.98

Volume

72.2K

Market Cap

$5.05M

About Bio Green Med Solution, Inc. Common Stock

Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 12 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$81.0K	$-988,000	$-1.31

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for BGMS yet. Check out our latest market news or earnings calendar.

Get BGMS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Bio Green Med Solution, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.